Table 4.
Type, time of occurrence, and duration of adverse effects in diabetic cats treated with exenatide ER or placebo
| Adverse effect | Exenatide ER | Placebo | P‐value | ||||
|---|---|---|---|---|---|---|---|
| Cats (n = 15) | Dpi | Between week | Cats (n = 15) | Dpi | Between week | ||
| Decreased appetite | 9 (60%) | 1–3 | 1–10 | 3 (20%) | 0–7 | 2–6 | .060 |
| Vomiting | 8 (53.3%) | 1–4 | 0–15 | 6 (40%) | 1–6 | 0–16 | .715 |
| Diarrhea | 1 (6.7%) | 6 | 1–14 | 3 (20%) | 1–3 | 1–14 | .598 |
| Increased sleeping | 5 (33.3%) | 1–3 | 1–6 | 1 (6.7%) | 1–3 | 0–6 | .169 |
| Hiding in dark areas | 3 (20%) | 0–3 | 0–3 | 1 (6.7%) | 1 | 9 | .598 |
Dpi, days postinjection.